Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Patients with newly diagnosed multiple myeloma and considered transplant ineligible (TIE) because of age, frailty and/or comorbidities now have access to highly effective therapies that can achieve deep and/or durable remission. TIE patients are a highly heterogeneous population whose biological and chronological age can vary substantially. The treatment of these patients can be challenging in clinical practice and requires a frailty-adapted, individualised approach with an emphasis on treatment deliverability and tolerability to optimise patient outcomes. Here, we summarise recommendations for TIE patients, including pre-treatment considerations, induction and maintenance therapies, and supportive care management.

Authors

Institutions

Publication Details

Journal
Internal Medicine Journal
Published
2026-01-08
DOI
https://doi.org/10.1111/imj.70329
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Silvia Ling, Andrew C.W. Zannettino, N Weber, Cindy H. Lee et al.
Internal Medicine Journal
Multiple Myeloma Research and Treatments
article

Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Silvia Ling, Andrew C.W. Zannettino, N Weber, Cindy H. Lee, Georgia J. B. McCaughan, Dipti Talaulikar, Angelina Yong, Shirlene Sim, D. E. Joshua, Peter N. Mollee, Simon James Harrison, Bradley Augustson, Andrew Spencer, P. Joy Ho, Hang Quach, H. Miles Prince, Anna Kalff
article en

Abstract

Patients with newly diagnosed multiple myeloma and considered transplant ineligible (TIE) because of age, frailty and/or comorbidities now have access to highly effective therapies that can achieve deep and/or durable remission. TIE patients are a highly heterogeneous population whose biological and chronological age can vary substantially. The treatment of these patients can be challenging in clinical practice and requires a frailty-adapted, individualised approach with an emphasis on treatment deliverability and tolerability to optimise patient outcomes. Here, we summarise recommendations for TIE patients, including pre-treatment considerations, induction and maintenance therapies, and supportive care management.

Internal Medicine JournalVol. 56(3)
Australian National University (AU), The University of Sydney (AU), Royal Adelaide Hospital (AU), The University of Queensland (AU), The University of Melbourne (AU), University of South Australia (AU), Royal Brisbane and Women's Hospital (AU), Royal Prince Alfred Hospital (AU), Epworth Hospital (AU), Peter MacCallum Cancer Centre (AU), Liverpool Hospital (AU), Princess Alexandra Hospital (AU), The Alfred Hospital (AU), Sir Charles Gairdner Hospital (AU), UNSW Sydney (AU), St Vincent's Hospital Melbourne (AU), St Vincent's Hospital Sydney (AU), Mental Health Australia (AU), Act Health (AU), Monash University (AU), The University of Adelaide (AU)
Openalex Percentile: Top 95%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.